Ultrasound eyebrow lift shows promise in clinical trial

NCT ID NCT06724510

Completed Symptom relief Sponsor: CLASSYS Inc. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed clinical trial tested a high-intensity focused ultrasound (HIFU) device called ULTRAFORMER MPT for lifting eyebrows without surgery. 180 adults aged 20-65 with mild to moderate forehead skin laxity received either a single HIFU treatment or no treatment. The study measured eyebrow lifting improvement using standardized photos and participant satisfaction over 3 months. Results suggest the device can effectively lift brows with an acceptable safety profile.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: high-intensity focused ultrasound (HIFU) device (ULTRAFORMER MPT)
What this could lead to: If proven effective, this device could offer a non-surgical option for lifting eyebrows, reducing the need for invasive procedures.
What could go wrong: This is a small, completed trial with short follow-up (3 months). Results may not last long-term, and individual results vary. Pain or temporary skin reactions are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FACIAL WRINKLES AND RHYTIDES REDUCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cutis laxa

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FACIAL WRINKLES AND RHYTIDES REDUCTION SKIN LAXITY WRINKLES

Contacts and locations

Locations

Beijing Anzhen Hospital of Capital Medical University

Beijing, China
Emergency General Hospital

Beijing, China
The Second Affiliated Hospital of Xian Jiaotong University

Xi'an, China
TheThird Hospital of Hebei Medical University

Shijiazhuang, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.